arrow
Y

Yuancheng Chen

fudan university
H指数:23
被引数:1,998

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Model-Informed Precision Dosing of Vancomycin in Chinese Adult Patients Receiving Renal Replacement Therapy: Systematic Evaluation of Published Pharmacokinetic Models and Dosing Regimen Simulations

基于模型指导的万古霉素在中国接受肾脏替代治疗成人患者中的精准给药:已发表药代动力学模型的系统评价与给药方案模拟

2025-09-030
PRE
Population pharmacokinetics and pharmacodynamics of eravacycline in patients with complicated intra-abdominal infections and community acquired bacterial pneumonia: support for a fixed-dose treatment regimen

厄他培南在复杂性腹腔内感染和社区获得性细菌性肺炎患者中的群体药代动力学和药效学研究:支持固定剂量治疗方案

2025-09-010
PRE
Population pharmacokinetics and pharmacodynamics of HFB30132A, a monoclonal antibody against SARS-CoV-2, in healthy Chinese and US subjects

HFB30132A(一种抗SARS-CoV-2的单克隆抗体)在健康中国受试者和美国受试者中的群体药代动力学和药效学研究

2025-03-010
PRE
Gut microbiota impacts bone via Bacteroides vulgatus-valeric acid-related pathways

肠道菌群通过普通拟杆菌-戊酸相关途径影响骨骼

2023-10-2716
OAAI
Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin

序列类型5 (ST5) 可能是万古霉素治疗的耐甲氧西林金黄色葡萄球菌肺炎成人患者的细菌持久性预测指标

2022-10-265
OAAI
Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study

中国成年患者中肾清除率增高与万古霉素药代动力学/药效学目标不达标之间的关联:一项前瞻性观察研究

2022-06-226
OAAI
Pharmacokinetics and Safety of Single-Dose Amphotericin B Colloidal Dispersion in Healthy Chinese Subjects and Population Pharmacokinetic/Pharmacodynamic Analysis to Inform Clinical Efficacy in Invasive Infections Caused by Candida albicans
2021-11-014
PRE